2014-02-13T09:58:44-07:00 2013-06-30 990 2012-07-01 730580274 OKLAHOMA MEDICAL RESEARCH FOUNDATION OKLA 4052717421 825 NE 13th Street Oklahoma City OK 73104 Tim Hassen 4052717421 2014-02-13 2012 2015-11-30 17:44:51Z Tim Hassen VP and CFO 825 NE 13th Street Oklahoma city OK 73104 61917849 0 X www.omrf.org X 1946 OK OMRF is dedicated to developing a better understanding of and more effective treatments for human disease. 76 76 543 0 0 0 56883620 51804565 1494341 3091109 2189314 3003873 3866635 3511838 64433910 61411385 0 0 0 0 32913559 32664419 0 0 1836781 35846936 34817797 68760495 67482216 -4326585 -6070831 371571744 379496939 63294489 61935982 308277255 317560957 OMRF is dedicated to developing a better understanding of and more effective treatments for human disease. 0 0 15614854 0 14698144 Arthritis and Clinical Immunology Research Program and Clinical Operations - Scientists in this research program continued to make a major impact on the study of the immune system, publishing a total of 78 different research papers in national and international scientific journals in 2013. This research consistently heralded new findings that deepened scientists' and physicians' understandings of lupus, multiple sclerosis and other conditions in which patients' bodies mistakenly turn the weapons the of their immune system against them. Highlights included the identification of six new genes believed to play a role in Sjogren's syndrome, a condition in which a person's white blood cells attack moisture-producing glands. OMRF scientists also led a pair of major initiatives that cast light on the origins of lupus, which affects more than 1 million Americans and remains one of the most problematic illnesses to diagnose and treat. Coupling this laboratory strength with Clinical Operations, which supports laboratory research through clinical studies and patient treatment, OMRF remains one of only two institutions selected by the National Institutes of Health as both an Autoimmunity Center of Excellence and a Center for Autoimmune Disease Prevention. 6321181 0 7833930 Cardiovascular Biology Research Program - One way the immune system keeps a body healthy is through immune surveillance. Lymphocytes, a type of white blood cell, constantly exit the bloodstream and "check in" at the lymph nodes to learn about possible pathogens or abnormal cell growth. The function prepares the immune system to fight infections and dispose of pre-cancerous cells. For years, scientists have wondered how lymphocytes exit the bloodstream at a large volume without causing bleeding. In 2013, a team of OMRF researchers found that platelets, which normally stop blood loss by clumping and forming plugs in blood vessel holes after injuries, activate a screening process. This process allows lymphocytes to exit into lymph nodes without letting red blood cells leave the blood vessel. Detailed in the journal Nature, these findings could alter the ways doctors use platelets to treat traumatic injuries and serious infections. 3520809 0 3285438 Immunobiology and Cancer Research Program - When people age, so do their cells. This process takes a particular toll on stem cells, which play a key role in fighting infections. "As stem cells grow older, their ability to make lymphocytes is diminished," says OMRF's Dr. Paul Kincade. "That compromises the body's ability to fight infections and could explain why older patients have so much more trouble fighting common illnesses." In collaboration with researchers at the Osaka University Graduate School of Medicine in Japan, Kincade helped stimulate the stem cells of laboratory mice to make more of a protein known as Satb1. The result: The animals' stem cells regained much of their ability to create lymphocytes. Published in 2013 in the journal Immunity, the findings might help replenish stem cells as people grow older and aid in reducing age-related illness from infections. "At least in mice," says Kincade, "this looks like a fountain of youth for the immune system." 36455654 0 9085781 Other Program Services 36455654 0 9085781 61912498 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 1 147 0 1 543 1 0 0 0 0 1 1 1 1 0 0 0 1 1 0 X 76 76 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 OK X X X Tim Hassen 4052717421 825 NE 13th Street Oklahoma City OK 73104 Allen Greg S 1 X 0 0 0 Anoatubby Bill 1 X 0 0 0 Bass Jim 1 X 0 0 0 Bell Sharon 1 X 0 0 0 Benbrook Bruce 1 X 0 0 0 Benham Lance 1 X 0 0 0 Boghetich Jil 1 X 0 0 0 Braught Barbara 1 X 0 0 0 Burgess Bill 1 X 0 0 0 Brown Randy 1 X 0 0 0 Burgess Ellen 1 X 0 0 0 Cameron Bill 1 X 0 0 0 Carolina Mike 1 X 0 0 0 Carroll Michael 1 X 0 0 0 Cason Len 1 X 0 0 0 Champlin Hiram 1 X 0 0 0 Collins Mark 1 X 0 0 0 Cox Rusty 1 X 0 0 0 Crawford Bill 1 X 0 0 0 Drake Ramsey 1 X 0 0 0 Duncan Walt 1 X 0 0 0 Eagan Claire 1 X 0 0 0 Edwards Carl 1 X 0 0 0 Evans Pat 1 X 0 0 0 Everest Christy 1 X 0 0 0 Felton Ann 1 X 0 0 0 Fergeson Ken 1 X 0 0 0 Ferree Larry 1 X 0 0 0 Fischer Malinda 1 X 0 0 0 Fretwell Barbara 1 X 0 0 0 Funke Mark 1 X 0 0 0 Gamble Gerald 1 X 0 0 0 Griffin John 1 X 0 0 0 Griffin Martha 1 X 0 0 0 Groendyke Virginia 1 X 0 0 0 Haglund Jacqui 1 X 0 0 0 Hall Brooks 1 X 0 0 0 Hargis Burns 1 X 0 0 0 Hawley Bill 1 X 0 0 0 Henry Kim 1 X 0 0 0 Henry Robert 1 X 0 0 0 Hogan Randy 1 X 0 0 0 Holmes Jerome 1 X 0 0 0 Hudson Cliff 1 X 0 0 0 Jameson Brett 1 X 0 0 0 Johnstone Bill 1 X 0 0 0 Kerr Lou 1 X 0 0 0 Levy Harrison 1 X 0 0 0 Little Dan 1 X 0 0 0 Loughridge Bill 1 X 0 0 0 McCarty Jack 1 X 0 0 0 McPherson Frank 1 X 0 0 0 Morris Jim 1 X 0 0 0 Mueller James 1 X 0 0 0 Nichols Larry 1 X 0 0 0 Parry Richard 1 X 0 0 0 Patten Rebecca 1 X 0 0 0 Payne Bond 1 X 0 0 0 Pierson Gary 1 X 0 0 0 Pitman Don 1 X 0 0 0 Rainbolt David 1 X 0 0 0 Replogle Dee 1 X 0 0 0 Rooney Pat 1 X 0 0 0 Ross Bob 1 X 0 0 0 Samis Mike 1 X 0 0 0 Saxon John 1 X 0 0 0 Schulte Paul 1 X 0 0 0 Stough Phyllis 1 X 0 0 0 Swimmer Ross 1 X 0 0 0 Switzer Becky 1 X 0 0 0 Taylor Steven 1 X 0 0 0 Thorpe Betsy 1 X 0 0 0 Walton Greg 1 X 0 0 0 Ward Lew 1 X 0 0 0 Williams Jr G Rainey 1 X 0 0 0 Wymer Deane 1 X 0 0 0 Prescott Stephen 50 0 X 1783086 0 129439 Paul Kincade 50 0 X 262919 0 36671 Morgan Chip 50 0 X 221826 0 33429 Cohen Adam 50 0 X 217394 0 31444 Voss Penny 50 0 X 197069 0 54427 Kennedy Larry 50 0 X 158298 0 24188 Hassen Tim 50 0 X 187555 0 33716 Day Lisa 50 0 X 111465 0 16578 James Judith 50 0 X 360022 0 35266 McEver Rodger 50 0 X 315207 0 41423 Pardo Gabriel 50 0 X 321017 0 41025 Husain Farhat 50 0 X 223094 0 33410 Gaffney Patrick 50 0 X 217414 0 37293 Sivils Kathy 50 0 X 214608 0 36404 Nath Swapan 50 0 X 202705 0 35059 Capra J Donald 10 0 X 124000 0 0 5117679 0 619772 46 1 1 0 Aramark 24863 Network Pl Chicago IL 606731248 HouseKeeping Services 491733 SAIC Energy Environment & Infastructure Rt 1 Box 223563 Pittsburgh PA 152512563 Architect 284850 Perkins Will PO Box 71181 Chicago IL 606941181 Architect 282553 SSM HEALTHCARE OF OKLAHOMA 1000 N Lee Ave Oklahoma City OK 73102 Medical Billing Services 175417 Fulbright Jaworski LLP PO Box 844284 Dallas TX 752844284 Legal 126275 6 140725 0 268654 0 33805458 17589728 113056 51804565 Clinical Revenue 621399 3091109 3091109 0 0 0 0 0 0 3091109 3307104 3307104 0 0 63612 63612 0 0 1571501 1571501 0 0 499780 0 0 0 499780 0 499780 499780 0 0 129650 9971 108730 397734 20920 -387763 -366843 -366843 0 0 0 268654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Cafe Income 722100 271114 271114 0 0 Laboratory Income 541380 1169443 1169443 0 0 0 0 0 0 1440557 61411385 9606820 0 0 4011911 2983869 830973 197069 21030929 19585248 553728 891953 7621579 6892812 387472 341295 0 0 0 0 0 0 0 0 176295 129634 46661 0 96850 71216 25634 0 384408 0 384408 0 0 0 0 0 0 0 1282724 1282724 0 0 0 0 0 0 579456 355101 71539 152816 632761 560101 43787 28873 0 0 0 0 3494466 2800065 694331 70 615844 549487 40851 25506 0 0 0 0 139847 134637 2353 2857 2706518 2633071 73447 0 0 0 0 0 8814346 8461284 353062 0 405185 301763 103422 0 Lab Supplies 5769469 5769469 0 0 Trainee Costs 1277787 1277787 0 0 Inhouse 1431371 1392358 24276 14737 Subcontracts 5373448 5373448 0 0 1637022 1358424 96993 181605 67482216 61912498 3732937 1836781 4300 4300 24927614 20254095 12081809 12181152 1435985 2035725 0 0 0 0 200937 257777 1818 3392 955509 738369 220370976 94472353 131546465 125898623 84084129 93587338 1368813 1182212 0 0 0 0 114964365 123353956 371571744 379496939 6178255 6579010 0 0 0 0 52923784 51933612 0 0 0 0 4192450 3423360 63294489 61935982 X 113874450 111634660 30782640 33262896 163620165 172663401 308277255 317560957 371571744 379496939 X -6070831 0 0 0 0 15354533 X 0 1 X 1 1 1 X 57098803 69877368 69070646 56883620 51804565 304735002 0 0 0 0 0 0 0 0 0 0 0 0 57098803 69877368 69070646 56883620 51804565 304735002 304735002 6967812 7117954 6803393 6055949 6515711 33460819 0 0 0 0 0 0 0 0 0 0 0 0 338195821 3091109 0.90106 0.75814 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 0 0 0 1 384408 0 0 384408 0 SchC_P2B_S00_L01 Schedule C, Part II-B, Line 1 The Foundation's lobbying activities entail monitoring proposed legislation and educating legislators and their staffs about the Foundation, medical research and the impact of proposed legislation on medical research and the Foundation. 66735078 3205030 9519982 0 3200000 0 76260090 69793689 76613 64776 0 3200000 0 66735078 58867420 237181 13989088 0 3300000 0 69793689 58951820 239636 2975964 0 3300000 0 58867420 73407691 1652223 -12908094 0 3200000 0 58951820 0.0733 0.687 0.2397 1 0 3944520 0 3944520 175433249 0 6177719 169255530 0 0 0 0 39179400 0 88294634 -49115234 1813807 0 0 1813807 125898623 Funds Held in Trust by Others 119956818 Wills & Bequests, Net 2010645 Cash Surrender Value of Life Insurance 675275 Debt Issue Costs 409715 Deposits 153706 Accrued Interest Receivable 99723 Assets held for sale 47970 Minerals 104 123353956 Split Interest Agreements & Other Liabilities 410608 Postretirement Benefits & Deferred Compensation 3012752 3423360 X 61411385 0 0 0 0 0 61411385 0 0 0 61411385 67482216 0 0 0 0 0 67482216 0 0 0 67482216 SchD_P05_S00_L04 Schedule D, Part V, Line 4 The Foundation's endowment consists of individual funds established to provide the Foundation with funding in perpetuity. SchD_P10_S00_L02 Schedule D, Part X, Line 2 Management has reviewed the Foundation's tax positions and concluded that there are no uncertain tax positions that require accrual in the financial statements or disclosure in the footnotes to be in compliance with authoritative literature. Generally, the Foundation is no longer subject to income tax examination by federal, state or local tax authorities for years prior to 2010. 241 Event 595390 0 595390 0 59838 0 23929 177007 65962 0 0 595390 0 595390 0 59838 0 23929 177007 65962 326736 268654 X 1 1 X X X X X X 0 1 0 0 0 0 0 1 0 Prescott Stephen 752664 0 205148 0 825275 0 116641 0 8655 0 1908383 0 733333 0 Paul Kincade 235106 0 3000 0 24813 0 27974 0 8697 0 299590 0 0 0 Morgan Chip 197043 0 0 0 24783 0 24775 0 8655 0 255256 0 0 0 Cohen Adam 215627 0 0 0 1767 0 24152 0 7292 0 248838 0 0 0 Voss Penny 177995 0 0 0 19074 0 41379 0 13048 0 251496 0 0 0 Kennedy Larry 154907 0 0 0 3391 0 15601 0 8588 0 182487 0 0 0 Hassen Tim 186178 0 0 0 1377 0 20679 0 13037 0 221271 0 0 0 Day Lisa 107465 0 100 0 3900 0 9532 0 7046 0 128043 0 0 0 James Judith 338932 0 3000 0 18090 0 27974 0 7292 0 395288 0 0 0 McEver Rodger 287912 0 3000 0 24295 0 27974 0 13051 0 356232 0 0 0 Pardo Gabriel 320576 0 0 0 441 0 27974 0 13051 0 362042 0 0 0 Husain Farhat 222326 0 0 0 768 0 24755 0 8655 0 256504 0 0 0 Gaffney Patrick 203338 0 0 0 14076 0 24242 0 13051 0 254707 0 0 0 Sivils Kathy 213198 0 0 0 1410 0 23353 0 13051 0 251012 0 0 0 Nath Swapan 194228 0 2000 0 6477 0 22008 0 13051 0 237764 0 0 0 SchJ_P01_S00_L01a Schedule J, Part I, Line 1a First class travel is allowed for the CEO to allow him to accomplish work related tasks while traveling. SchJ_P01_S00_L03 Schedule J, Part I, Line 3 Compensation for the CEO is determined by leadership of the board of directors based on comparability data from widely accepted peer benchmarking surveys that are segmented by region and size of entity. SchJ_P01_S00_L04 Schedule J, Part I, Line 4 The Board of the Foundation periodically uses nonqualified retirement plans as a retention tool. SchJ_P01_S00_L07 Schedule J, Part I, Line 7 The CEO receives an annual bonus that is determined by leadership of the board of directors based on performance. The bonus is considered as a portion of total compensation and is subject to the review process previously described. A Oklahoma Industries Authority 736194355 679103YC9 2008-08-14 42955000 Revenue Bonds (OMRF Project) Series 2008 0 0 0 B Oklahoma Industries Authority 736194355 XXNONEXXX 2010-05-26 12185000 Revenue Bonds (OMRF Project) Series 2010 0 0 0 A 4000000 0 43457720 3316750 0 0 141976 0 0 30540129 0 9458865 2011 0 0 0 1 B 0 0 12320300 1218339 0 0 138825 0 0 0 10963136 0 2011 0 1 1 1 A 0 0 0 1 1 0 0 0 1 0 1 B 0 0 0 1 1 0 0 0 1 0 1 A 0 1 0 0 0 0 0 1 1 B 0 0 0 1 0 0 0 0 1 SchK_P04_S00_L02c Schedule K, Part IV, Line 2c No rebate was due according to the rebate calculated November 21, 2013 for the rebate period beginning May 26, 2010 through June 30, 2013. Accele Biopharm Common Directors 200000 Joint venture investment 0 Accele Venture Partners Common Directors 152389 Joint venture investment 0 Bank of Oklahoma Common Directors 110016 Investment and mineral asset management 0 Ginny Bass Carl Related to Board member 95000 Payroll 0 Peter Carl Related to Board member 53685 Payroll 0 Presbyterian Health Foundation Common Directors 35728 Rental expense for building space 0 McAfee & Taft Common Directors 33025 Legal services 0 X 23 113056 FMV 0 0 1 1 SchM_P01_S00_L32b Schedule M, Part I, Line 32b A third party is used to sell gifts of stocks or bonds received from donors. Usually the donor transfers the stocks directly from their brokerage account into OMRF's third party account. Occasionally, OMRF receives stock certificates and those are sent directly to the third party to process. F990_P06_S0A_L01a Form 990, Part VI, Section A, Line 1a The Foundation's Board of Directors has delegated all of its powers to the Foundation's Executive Committee, except as follows: establish the overall policies and direction of the Foundation, appoint the members of the Executive Committee, elect and remove the Chair of the Board of Directors, amend the Bylaws and the Certificate of Incorporation of the Foundation, and appoint special committees to the Board of Directors. The Board of Directors may at any time amend or revoke this delegation of powers. F990_P06_S0A_L02 Form 990, Part VI, Section A, Line 2 The Foundation currently has 87 directors, many of whom are business leaders and members of prominent families in the State of Oklahoma. The Foundation believes there are multiple business relationships between and among board members and families of Board members, but the Foundation review of signed conflict of interest disclosures from all board members and of the Foundation's ledger accounts indicated there are no such relationships that would impair the fiduciary duties of any director to the Foundation. F990_P06_S0B_L11b Form 990, Part VI, Section B, Line 11b A summary of the Form 990 is presented for review to the Executive Committee. Subsequent to that review, the Form 990 with all supplemental schedules is made available to all members of the board of directors for review and comment prior to filing. F990_P06_S0B_L12c Form 990, Part VI, Section B, Line 12c Each director, office and key employee is annually provided with a copy of the Foundation's conflict of interest policy. Each of these individuals is annually provided with a questionnaire regarding potential conflicts and required to disclose any potential conflict that he or she might have. In addition, each of these individuals must annually sign a statement affirming that he or she has; received a copy of the conflicts of interest policy, read and understood the policy and agrees to comply with the policy. Once the Foundation has collected annual disclosure statements from all directors, officer and key employees, the Foundation's Governance committee review such information to identify situations in which a conflict exists and is material. If a material conflict is identified, the committee analyzes whether the contemplated transaction may be authorized as just, fair, and reasonable to the Foundation. The Governance Committee then makes a recommendation to the Foundations' Executive Committee regarding the management of all potential conflicts it has identified. The final decision as to the approval and , where applicable, management of all such potential conflicts rests in the sole discretion of the Executive Committee, which make such decisions based upon the welfare of the Foundation and the advancement of its purpose. The recommendations of the Governance Committee and decisions of the Executive Committee are documented in the respective minutes of these Committees' regular meetings. F990_P06_S0B_L15 Form 990, Part VI, Section B, Line 15 Compensation for Officers is determined and evaluated in May of each year by leadership of the board of directors based on comparability data from widely accepted peer benchmarking salary surveys that are segmented by region and size of entity. Compensation for principal investigators (lead researchers), including any key employees, is determined by Foundation Officers based on the comparability data referenced above and evaluated in May of each year. F990_P06_S0C_L19 Form 990, Part VI, Section C, Line 19 The Foundation's governing documents, conflicts of interest policy, and financial statements are provided upon request and are publicly available on the Foundation's website. F990_P11_S00_L09 Form 990, Part XI, Line 9 Includes decrease in fair value of funds held in trust by others, net investment losses in excess of gains (losses) designated for operations and pension related changes other than net periodic pension costs.